Skip to main content
Erschienen in: Obesity Surgery 8/2019

10.05.2019 | Original Contributions

Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy

verfasst von: Tannaz Jamialahmadi, Mohsen Nematy, Ali Jangjoo, Ladan Goshayeshi, Reza Rezvani, Kamran Ghaffarzadegan, Mehdi Jabbari Nooghabi, Payman Shalchian, Mahtab Zangui, Zeinab Javid, Saeid Doaei, Farnood Rajabzadeh

Erschienen in: Obesity Surgery | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Nonalcoholic fatty liver disease (NAFLD) is common among severely obese patients. Two-dimensional shear wave elastography (2D-SWE) has been validated as a noninvasive diagnostic tool for liver stiffness measurement. However, the technical feasibility and accuracy of this method in severely obese patients are still under debate.

Objective

We aimed to assess the diagnostic accuracy of 2D-SWE in bariatric surgery candidates in comparison with the gold standard liver biopsy.

Methods

Ninety severely obese candidates for bariatric surgery were included. Liver stiffness was measured using 2D-SWE 14 days before liver biopsy. Liver biopsy was taken on the day of surgery. The area under the receiver operating curve (AUROC) was calculated for the staging of liver fibrosis.

Results

2D-SWE was performed in 97.3% of patients successfully. Histologic stages of fibrosis (F0-F4) were detected in 34.2%, 36%, 6.3%, 3.6%, and 0.9% of patients, respectively. The AUROC for 2D-SWE was 0.77 for F1, 0.72 for F2, 0.77 for F3, and 0.70 for F4. In univariate analysis, 2D-SWE values were correlated with BMI, waist circumference, NAFLD activity score (NAS), and steatosis, whereas these components did not affect liver stiffness in multivariate analysis.

Conclusion

Two-dimensional shear wave elastography of the liver can be feasible and has good accuracy in severely obese candidates for bariatric surgery. Therefore, 2D-SWE may be a good option for assessing liver fibrosis, especially in the early stages of fibrosis to lessen complications of surgery in this population. However, this method should be applied on a larger scale for late stage of fibrosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Roychowdhury S, Selvakumar PC, Cresci GAM. The role of the gut microbiome in nonalcoholic fatty liver disease. Med Sci (Basel). 2018;5:6(2)CrossRef Roychowdhury S, Selvakumar PC, Cresci GAM. The role of the gut microbiome in nonalcoholic fatty liver disease. Med Sci (Basel). 2018;5:6(2)CrossRef
2.
Zurück zum Zitat Traussnigg S, Kienbacher C, Halilbasic E, et al. Challenges and management of liver cirrhosis: practical issues in the therapy of patients with cirrhosis due to NAFLD and NASH. Dig Dis. 2015;33(4):598–607.CrossRef Traussnigg S, Kienbacher C, Halilbasic E, et al. Challenges and management of liver cirrhosis: practical issues in the therapy of patients with cirrhosis due to NAFLD and NASH. Dig Dis. 2015;33(4):598–607.CrossRef
3.
Zurück zum Zitat Taitano AA, Markow M, Finan JE, et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429–37.CrossRef Taitano AA, Markow M, Finan JE, et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429–37.CrossRef
4.
Zurück zum Zitat Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379–88.CrossRef Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379–88.CrossRef
5.
Zurück zum Zitat Aykut UE, Akyuz U, Yesil A, et al. A comparison of FibroMeter NAFLD score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scand J Gastroenterol. 2014;49(11):1343–8.CrossRef Aykut UE, Akyuz U, Yesil A, et al. A comparison of FibroMeter NAFLD score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scand J Gastroenterol. 2014;49(11):1343–8.CrossRef
6.
Zurück zum Zitat Cassinotto C, Boursier J, de Ledinghen V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology (Baltimore, Md). 2016;63(6):1817–27.CrossRef Cassinotto C, Boursier J, de Ledinghen V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology (Baltimore, Md). 2016;63(6):1817–27.CrossRef
7.
Zurück zum Zitat Xie LT, Yan CH, Zhao QY, et al. Quantitative and noninvasive assessment of chronic liver diseases using two-dimensional shear wave elastography. World J Gastroenterol. 2018;24(9):957–70.CrossRef Xie LT, Yan CH, Zhao QY, et al. Quantitative and noninvasive assessment of chronic liver diseases using two-dimensional shear wave elastography. World J Gastroenterol. 2018;24(9):957–70.CrossRef
8.
Zurück zum Zitat Kemp W, Roberts S. FibroScan and transient elastography. Aust Fam Physician. 2013;42(7):468–71. Kemp W, Roberts S. FibroScan and transient elastography. Aust Fam Physician. 2013;42(7):468–71.
9.
Zurück zum Zitat Uppot RN, Sahani DV, Hahn PF, et al. Impact of obesity on medical imaging and image-guided intervention. Am J Roentgenol. 2007;188(2):433–40.CrossRef Uppot RN, Sahani DV, Hahn PF, et al. Impact of obesity on medical imaging and image-guided intervention. Am J Roentgenol. 2007;188(2):433–40.CrossRef
10.
Zurück zum Zitat Herrmann E, de Ledinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67(1):260–272.CrossRef Herrmann E, de Ledinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67(1):260–272.CrossRef
11.
Zurück zum Zitat Ooi GJ, Earnest A, Kemp WW, et al. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity. Int J Obes (Lond). 2018;42(11):1900–1911. CrossRef Ooi GJ, Earnest A, Kemp WW, et al. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity. Int J Obes (Lond). 2018;42(11):1900–1911.  CrossRef
12.
Zurück zum Zitat Praveenraj P, Gomes RM, Basuraju S, et al. Preliminary evaluation of acoustic radiation force impulse shear wave imaging to detect hepatic fibrosis in morbidly obese patients before bariatric surgery. J Laparoendosc Adv Surg Tech A. 2016;26(3):192–5.CrossRef Praveenraj P, Gomes RM, Basuraju S, et al. Preliminary evaluation of acoustic radiation force impulse shear wave imaging to detect hepatic fibrosis in morbidly obese patients before bariatric surgery. J Laparoendosc Adv Surg Tech A. 2016;26(3):192–5.CrossRef
13.
Zurück zum Zitat Ooi GJ, Mgaieth S, Eslick GD, et al. Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese. Obes Rev. 2018;19(2):281–294.CrossRef Ooi GJ, Mgaieth S, Eslick GD, et al. Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese. Obes Rev. 2018;19(2):281–294.CrossRef
14.
Zurück zum Zitat Jo V. Cytopathology, An Issue of Surgical Pathology Clinics: Elsevier Health Sciences 2018. Jo V. Cytopathology, An Issue of Surgical Pathology Clinics: Elsevier Health Sciences 2018.
15.
Zurück zum Zitat Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598–607.e2.CrossRef Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598–607.e2.CrossRef
16.
Zurück zum Zitat Barr RG, Ferraioli G, Palmeri ML, et al. Elastography assessment of liver fibrosis: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2015;276(3):845–61.CrossRef Barr RG, Ferraioli G, Palmeri ML, et al. Elastography assessment of liver fibrosis: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2015;276(3):845–61.CrossRef
17.
Zurück zum Zitat Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biometrical journal Biom J. 2005;47(4):458–72.CrossRef Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biometrical journal Biom J. 2005;47(4):458–72.CrossRef
18.
Zurück zum Zitat Paul SB, Das P, Mahanta M, et al. Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastography. Abdominal Radiol (New York). 2017;42(12):2864–73.CrossRef Paul SB, Das P, Mahanta M, et al. Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastography. Abdominal Radiol (New York). 2017;42(12):2864–73.CrossRef
19.
Zurück zum Zitat Mancini M, Salomone Megna A, Ragucci M, et al. Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease. PLoS One. 2017;12(10):e0185391.CrossRef Mancini M, Salomone Megna A, Ragucci M, et al. Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease. PLoS One. 2017;12(10):e0185391.CrossRef
20.
Zurück zum Zitat Li C, Zhang C, Li J, et al. Diagnostic accuracy of real-time shear wave elastography for staging of liver fibrosis: a meta-analysis. Med Sci Monit. 2016;22:1349–59.CrossRef Li C, Zhang C, Li J, et al. Diagnostic accuracy of real-time shear wave elastography for staging of liver fibrosis: a meta-analysis. Med Sci Monit. 2016;22:1349–59.CrossRef
21.
Zurück zum Zitat Jiang T, Tian G, Zhao Q, et al. Diagnostic accuracy of 2D-shear wave elastography for liver fibrosis severity: a meta-analysis. PLoS One. 2016;11(6):e0157219.CrossRef Jiang T, Tian G, Zhao Q, et al. Diagnostic accuracy of 2D-shear wave elastography for liver fibrosis severity: a meta-analysis. PLoS One. 2016;11(6):e0157219.CrossRef
22.
Zurück zum Zitat Bruce M, Kolokythas O, Ferraioli G, et al. Limitations and artifacts in shear-wave elastography of the liver. Biomed Eng Lett. 2017;7(2):81–9.CrossRef Bruce M, Kolokythas O, Ferraioli G, et al. Limitations and artifacts in shear-wave elastography of the liver. Biomed Eng Lett. 2017;7(2):81–9.CrossRef
23.
Zurück zum Zitat Brener S. Transient Elastography for assessment of liver fibrosis and steatosis: an evidence-based analysis. Ontario Health Technol Assessment Ser. 2015;15(18):1–45. Brener S. Transient Elastography for assessment of liver fibrosis and steatosis: an evidence-based analysis. Ontario Health Technol Assessment Ser. 2015;15(18):1–45.
24.
Zurück zum Zitat Friedrich-Rust M, Poynard T, Castera L. Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol. 2016;13(7):402–11.CrossRef Friedrich-Rust M, Poynard T, Castera L. Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol. 2016;13(7):402–11.CrossRef
25.
Zurück zum Zitat Agbim U, Asrani SK. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. Expert Rev Gastroenterol Hepatol. 2019;13(4):361–374. CrossRef Agbim U, Asrani SK. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. Expert Rev Gastroenterol Hepatol. 2019;13(4):361–374. CrossRef
26.
Zurück zum Zitat Feng JC, Li J, Wu XW, et al. Diagnostic accuracy of SuperSonic shear imaging for staging of liver fibrosis: a meta-analysis. J Ultrasound Med. 2016;35(2):329–39.CrossRef Feng JC, Li J, Wu XW, et al. Diagnostic accuracy of SuperSonic shear imaging for staging of liver fibrosis: a meta-analysis. J Ultrasound Med. 2016;35(2):329–39.CrossRef
27.
Zurück zum Zitat Leung VY-F, Shen J, Wong VW-S, et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. Radiology. 2013;269(3):910–8.CrossRef Leung VY-F, Shen J, Wong VW-S, et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. Radiology. 2013;269(3):910–8.CrossRef
28.
Zurück zum Zitat Ferraioli G, Tinelli C, Dal Bello B, et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology (Baltimore, Md). 2012;56(6):2125–33.CrossRef Ferraioli G, Tinelli C, Dal Bello B, et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology (Baltimore, Md). 2012;56(6):2125–33.CrossRef
29.
Zurück zum Zitat Cassinotto C, Lapuyade B, Mouries A, et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of supersonic shear imaging with ARFI and FibroScan®. J Hepatol. 2014;61(3):550–7.CrossRef Cassinotto C, Lapuyade B, Mouries A, et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of supersonic shear imaging with ARFI and FibroScan®. J Hepatol. 2014;61(3):550–7.CrossRef
30.
Zurück zum Zitat Gerber L, Kasper D, Fitting D, et al. Assessment of liver fibrosis with 2-D shear wave elastography in comparison to transient elastography and acoustic radiation force impulse imaging in patients with chronic liver disease. Ultrasound Med Biol. 2015;41(9):2350–9.CrossRef Gerber L, Kasper D, Fitting D, et al. Assessment of liver fibrosis with 2-D shear wave elastography in comparison to transient elastography and acoustic radiation force impulse imaging in patients with chronic liver disease. Ultrasound Med Biol. 2015;41(9):2350–9.CrossRef
31.
Zurück zum Zitat Ferraioli G, Parekh P, Levitov AB, et al. Shear wave elastography for evaluation of liver fibrosis. J Ultrasound Med. 2014;33(2):197–203.CrossRef Ferraioli G, Parekh P, Levitov AB, et al. Shear wave elastography for evaluation of liver fibrosis. J Ultrasound Med. 2014;33(2):197–203.CrossRef
32.
Zurück zum Zitat Naveau S, Lamouri K, Pourcher G, et al. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg. 2014;24(10):1693–701.CrossRef Naveau S, Lamouri K, Pourcher G, et al. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg. 2014;24(10):1693–701.CrossRef
33.
Zurück zum Zitat Samir AE, Dhyani M, Vij A, et al. Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology. 2015;274(3):888–96.CrossRef Samir AE, Dhyani M, Vij A, et al. Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology. 2015;274(3):888–96.CrossRef
34.
Zurück zum Zitat Poynard T, Pham T, Perazzo H, et al. Real-time shear wave versus transient elastography for predicting fibrosis: applicability, and impact of inflammation and steatosis. A Non-Invasive Comparison. PLoS One. 2016;11(10):e0163276.CrossRef Poynard T, Pham T, Perazzo H, et al. Real-time shear wave versus transient elastography for predicting fibrosis: applicability, and impact of inflammation and steatosis. A Non-Invasive Comparison. PLoS One. 2016;11(10):e0163276.CrossRef
35.
Zurück zum Zitat de Lédinghen V, Wong VW-S, Vergniol J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J Hepatol. 2012;56(4):833–9. de Lédinghen V, Wong VW-S, Vergniol J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J Hepatol. 2012;56(4):833–9.
36.
Zurück zum Zitat Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md). 2003;38(6):1449–57.CrossRef Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md). 2003;38(6):1449–57.CrossRef
37.
Zurück zum Zitat Poynard T, Lenaour G, Vaillant JC, et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol. 2012;10(6):657–63. e7.CrossRef Poynard T, Lenaour G, Vaillant JC, et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol. 2012;10(6):657–63. e7.CrossRef
38.
Zurück zum Zitat Teixeira ARF, Bellodi-Privato M, Carvalheira JB, et al. The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory. Obes Surg. 2009;19(12):1678–84.CrossRef Teixeira ARF, Bellodi-Privato M, Carvalheira JB, et al. The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory. Obes Surg. 2009;19(12):1678–84.CrossRef
39.
Zurück zum Zitat Lassailly G, Caiazzo R, Hollebecque A, et al. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol. 2011;23(6):499–506.CrossRef Lassailly G, Caiazzo R, Hollebecque A, et al. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol. 2011;23(6):499–506.CrossRef
40.
Zurück zum Zitat Francque SM, Verrijken A, Mertens I, et al. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol. 2012;10(10):1162–8.CrossRef Francque SM, Verrijken A, Mertens I, et al. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol. 2012;10(10):1162–8.CrossRef
41.
Zurück zum Zitat Ooi GJ, Burton PR, Doyle L, et al. Effects of bariatric surgery on liver function tests in patients with nonalcoholic fatty liver disease. Obes Surg. 2017;27(6):1533–42.CrossRef Ooi GJ, Burton PR, Doyle L, et al. Effects of bariatric surgery on liver function tests in patients with nonalcoholic fatty liver disease. Obes Surg. 2017;27(6):1533–42.CrossRef
Metadaten
Titel
Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy
verfasst von
Tannaz Jamialahmadi
Mohsen Nematy
Ali Jangjoo
Ladan Goshayeshi
Reza Rezvani
Kamran Ghaffarzadegan
Mehdi Jabbari Nooghabi
Payman Shalchian
Mahtab Zangui
Zeinab Javid
Saeid Doaei
Farnood Rajabzadeh
Publikationsdatum
10.05.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 8/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-03889-2

Weitere Artikel der Ausgabe 8/2019

Obesity Surgery 8/2019 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.